lupus and pulmonary hypertension

Systemic Lupus Erythematosus (SLE) is an autoimmune disorder that can potentially result in Pulmonary Arterial Hypertension (PAH), a serious condition that impacts the functionality of the heart and lungs. PAH is characterized by an abnormally elevated blood pressure in the pulmonary arteries, which may impose an increased workload on the right ventricle of the heart, potentially leading to heart failure. While not all individuals with SLE will develop PAH, awareness of its potential risks and symptoms is essential for early detection and management.

In examining the link between SLE and PAH, it's important to note that pulmonary complications are not universal among SLE patients. When they do occur, these complications can vary from mild shortness of breath to severe PAH. Mild shortness of breath might stem from pulmonary inflammation or pleurisy, whereas severe PAH could involve structural alterations in the pulmonary vasculature, increasing the resistance to blood flow. Additionally, certain treatments, such as prolonged use of corticosteroids or other immunosuppressive medications, might adversely impact lung health.

For individuals with SLE, it is vital to regularly monitor lung function and vigilantly observe any new or exacerbating respiratory symptoms. Persistent symptoms like shortness of breath, cough, or chest pain should prompt a timely medical evaluation. Regarding treatment, adherence to medical professionals' instructions is crucial; self-adjustment of medication dosages or discontinuation of medication is not recommended. Moreover, maintaining a healthy lifestyle, including smoking cessation, moderate physical activity, and a balanced diet, can contribute to better overall health.